New York A 5354: Provides for certain uses of premises for which no duty is owed to keep premises safe and the inherent risk of use of off highway recreational vehicles

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A05354 Summary:

BILL NOA05354 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORSteck

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Amd §§3216, 3221 & 4303, Ins L

&nbsp

Requires health insurers to provide coverage without cost-sharing for opioid antagonists and devices; provides that no prior authorization of premedical review for coverage of such opioid antagonist is required.

Go to top A05354 Actions:

BILL NOA05354 

&nbsp

02/13/2025referred to insurance

01/07/2026referred to insurance

Go to topA05354 Committee&nbspVotes:

Go to topA05354 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA05354 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 5354

 2025-2026 Regular Sessions

 IN ASSEMBLY

 February 13, 2025
 ___________

 Introduced by M. of A. STECK -- read once and referred to the Committee
 on Insurance

 AN ACT to amend the insurance law, in relation to requiring health
 insurers to provide coverage without cost-sharing for opioid antag-
 onists and devices

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Subsection (i) of section 3216 of the insurance law is
 2 amended by adding a new paragraph 40 to read as follows:
 3 (40) (A) (i) Every policy which provides coverage for prescription
 4 drugs shall include coverage for at least one opioid antagonist and
 5 device. No prior authorization or premedical review for coverage of an
 6 opioid antagonist is required.
 7 (ii) As used in this paragraph "opioid antagonist and device" means a
 8 drug approved by the food and drug administration that, when adminis-
 9 tered, negates or neutralizes in whole or in part the pharmacological
 10 effects of an opioid in the body. "Opioid antagonist" shall be limited
 11 to medications approved by the department of health for such purpose.
 12 (B) The coverage mandated by this paragraph shall include opioid
 13 antagonists prescribed or dispensed via standing order or collaborative
 14 practice agreement intended for use on patients other than the insured.
 15 (C) A policy shall not impose a deductible, co-insurance, co-payment,
 16 or any other cost-sharing requirement on such coverage provided pursuant
 17 to this paragraph.
 18 § 2. Subsection (l) of section 3221 of the insurance law is amended by
 19 adding a new paragraph 7-c to read as follows:
 20 (7-c) (A) (i) Every policy which provides coverage for prescription
 21 drugs shall include coverage for at least one opioid antagonist and
 22 device. No prior authorization or premedical review for coverage of an
 23 opioid antagonist is required.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD07388-02-5

 A. 5354 2

 1 (ii) As used in this paragraph "opioid antagonist and device" means a
 2 drug approved by the food and drug administration that, when adminis-
 3 tered, negates or neutralizes in whole or in part the pharmacological
 4 effects of an opioid in the body. "Opioid antagonist" shall be limited
 5 to medications approved by the department of health for such purpose.
 6 (B) The coverage mandated by this paragraph shall include opioid
 7 antagonists prescribed or dispensed via standing order or collaborative
 8 practice agreement intended for use on patients other than the insured.
 9 (C) A group or blanket policy subject to this paragraph shall not
 10 impose a deductible, co-insurance, co-payment, or any other cost-sharing
 11 requirement on such coverage provided pursuant to this paragraph.
 12 § 3. Section 4303 of the insurance law is amended by adding a new
 13 subsection (ww) to read as follows:
 14 (ww) (1) (A) Every policy that is issued, amended, renewed, effective,
 15 or delivered on or after January first, two thousand twenty-six and
 16 provides coverage for prescription drugs shall include coverage for at
 17 least one opioid antagonist and device. No prior authorization or
 18 premedical review for coverage of an opioid antagonist is required.
 19 (B) As used in this subsection "opioid antagonist and device" means a
 20 drug approved by the food and drug administration that, when adminis-
 21 tered, negates or neutralizes in whole or in part the pharmacological
 22 effects o